MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia.
|
24344687 |
2013 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Biallelic mutations in the YARS2 gene encoding mitochondrial tyrosyl-tRNA synthetase cause myopathy, lactic acidosis, and sideroblastic anemia 2 (MLASA2), a type of mitochondrial disease.
|
24430573 |
2014 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.
|
20598274 |
2010 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
GeneticVariation
|
disease |
UNIPROT |
A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia.
|
22504945 |
2012 |
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2
|
0.620 |
GeneticVariation
|
disease |
UNIPROT |
Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome.
|
20598274 |
2010 |
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA
|
0.560 |
GermlineCausalMutation
|
disease |
ORPHANET |
This study confirms mutations in YARS2 as a cause of MLASA and shows that, like some of the cytoplasmic ARSs, mitochondrial ARSs occur in high-molecular-weight complexes.
|
22504945 |
2012 |
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA
|
0.560 |
GermlineCausalMutation
|
disease |
ORPHANET |
A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2.
|
24430573 |
2014 |
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA
|
0.560 |
GermlineCausalMutation
|
disease |
ORPHANET |
MLASA has previously been associated with PUS1 mutations; hence, the YARS2 mutation reported here is an alternative cause of MLASA.
|
20598274 |
2010 |
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA
|
0.560 |
GermlineCausalMutation
|
disease |
ORPHANET |
In this study we have identified novel YARS2 mutations and noted marked phenotypic variability among YARS2 MLASA patients, with phenotypes ranging from mild to lethal, and we suggest that the background mtDNA haplotype may be contributing to the phenotypic variability.
|
24344687 |
2013 |
Myopathy
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Mitochondrial Myopathies
|
0.110 |
Biomarker
|
group |
HPO |
|
|
|
Acidosis, Lactic
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sideroblastic anemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blepharoptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Glaucoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Kyphosis deformity of spine
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Micrognathism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ptosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|